|
|
|
|
Hepatology Current Events | Hepatology News Hepatology current events and Hepatology news stories from Brightsurf. Find the latest Hepatology research, discoveries and most popular current news and events. |
| Page 1 of 7 | 127 Results |
|
|
| Sort By: Most Viewed Hepatology Current Events | Recent Hepatology Current Events |
GERD-related inflammation may contribute to esophageal cancer risk
Inflammation might be an important factor in the progression from reflux to esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. View More (2012-05-11)
Gastroenterology/hepatology societies release report evaluating fellowship training curriculum
Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training." View More (2009-11-04)
Pain characteristics suggest higher benefit from gallbladder surgery
According to a new study in Clinical Gastroenterology and Hepatology, better understanding of a patient's abdominal pain could help physicians know which patients will benefit most from surgical removal of the gallbladder. View More (2011-10-13)
Study confirms colonoscopy associated with reduced colorectal cancer incidence
Patients who undergo a complete negative colonoscopy have a reduced incidence of colorectal cancer, confirms a study published in Clinical Gastroenterology and Hepatology. View More (2008-10-03)
Treating hepatitis C infection in prison is good public policy
Incarcerated patients with chronic hepatitis C virus (HCV) infection are just as likely to respond to treatment for the disease as patients in the community, according to findings published in the October issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases. View More (2012-09-28)
Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment (SVR12). View More (2011-04-04)
Severe sleep apnea may be a risk factor for liver damage
Many patients with obstructive sleep apnea (OSA) are obese and therefore at risk of having fatty liver, a condition in which fat accumulates in the liver cells. But the link between OSA and liver injury independent of weight has yet to be examined. View More (2005-05-25)
Injecting botox into stomach does not promote weight los
Despite conflicting data in support of the practice, some overweight Americans looking for an easy fix have turned to gastric botox injections to help them lose weight. View More (2013-01-29)
High rates of disability and health care use found in older Americans with cirrhosis
Older patients with cirrhosis have significant functional disability, require twice the amount of informal caregiving, and contribute added strain on the health care system, according to U-M research published in Hepatology. View More (2012-01-11)
VCU researchers identify changes in cholesterol metabolic pathways
A new study from the Virginia Commonwealth University School of Medicine has identified molecular changes responsible for abnormal cholesterol production and metabolism in the livers of patients with a common liver condition, and these changes may explain the severity of a patient's liver disease and risks to their heart health. View More (2012-06-08)
Childhood obesity linked to increased risk of hepatocellular carcinoma in adulthood
Childhood obesity is a widespread global epidemic and in parallel with non-alcoholic fatty liver disease (NAFLD) is now the leading cause of liver disease among children. View More (2012-04-19)
Thalidomide shows efficacy as adjuvant therapy for hepatocellular carcinoma patients
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver CongressTM 2011. View More (2011-04-04)
Toxic Bile Damages the Liver
Researchers at the Heidelberg University Hospital have discovered a new genetic disease that can lead to severe liver damage. Because a protective component of the bile is missing, the liver cells are exposed to the toxic components of the bile, resulting in cirrhosis of liver, a transformation of liver cells into connective tissue with a gradual loss of liver function. View More (2008-10-27)
Environmental pollution increases the risk of liver disease
A new study is the first to show that there is a previously unrecognized role for environmental pollution in liver disease in the general U.S. adult population. View More (2009-05-29)
Adverse events rate is low when propofol is administered by trained professional
Propofol is safe for advanced endoscopic procedures with a low rate of sedation-related adverse events when administered by a trained professional, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. View More (2010-03-04)
Adult antiviral drug effective in suppressing hepatitis B in teens
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). View More (2012-12-06)
Even low-dose aspirin may increase risk of GI bleeding
The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. View More (2011-09-13)
Increased fructose consumption may deplete cellular energy in patients with obesity and diabetes
Obese people who consume increased amounts of fructose, a type of sugar that is found in particular in soft drinks and fruit juices, are at risk for nonalcoholic fatty liver disease (NFALD) and more its more severe forms, fatty inflammation and scarring. View More (2012-05-03)
Good news for some hard-to-treat hepatitis C patients
In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. View More (2009-06-16)
GERD patient satisfaction hinges on medication type and physician bedside manner
Patient satisfaction with their medications and the quality of interactions with their doctor reflect the success of gastroesophageal reflux disease (GERD) therapy, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. View More (2009-08-03)
|
|
| Page 1 of 7 | 127 Results |
|
|
| Sort By: Most Viewed Hepatology Current Events | Recent Hepatology Current Events |
|
|
